Janssen Search
Search results
Our Story
We focus our efforts and resources where the need is high, the science is compelling and where we have the greatest opportunity to save and improve lives. Who We Are Who is Janssen? We’re more than 30,000 people working hard to prevent, treat, cure and ...
World Diabetes Day 2016
Janssen Set on Diabetes and Its Life-Threatening Complications Every six seconds someone dies from diabetes. In 2015, diabetes claimed the lives of 5 million people worldwide. As the number of people with diabetes grows, so will this death toll, unless ...
Hematologic Malignancies (Blood Cancers)
Hematologic Malignancies (Blood Cancers) There has been significant progress in the treatment of people diagnosed with blood cancers over the past 50 years. Our leadership has advanced transformative therapies for hematologic malignancies, and we are ...
IDV Newsroom
Welcome to the Janssen Infectious Diseases & Vaccines Virtual Newsroom Janssen’s Commitment to Combating Infectious Diseases A Message from Penny Heaton and James Merson At Janssen, we have a strong legacy of daring to deliver medicines and vaccines ...
Mathai Mammen, M.D., Ph.D., Leaves Position as Executive Vice President, Pharmaceuticals, R&D, Johnson & Johnson
Aug 08, 2022 United States NEW BRUNSWICK, N.J., Aug. 8, 2022- Johnson & Johnson (NYSE: JNJ) (“the Company”) announced today that Mathai Mammen, M.D., Ph.D., has decided to leave his position as Executive Vice President, Pharmaceuticals, R&D, and ...
Change Is Coming
Change is Coming. It’s About Time, and We are Ready. Having worked at the Johnson & Johnson Family of Companies for almost 25 years, I've seen first-hand the commitment my company has had to positive change. Because of this, I’m excited to ...
Building a Better Tomorrow for All
Building a Better Tomorrow for All For decades, vaccines have had an unparalleled impact on global public health and remain one of the most effective methods of preventing infectious diseases worldwide. This year, the World Health Organization (WHO) ...
Progress in the Journey to Transform the Treatment of Bladder Cancer
Progress in the Journey to Transform the Treatment of Bladder Cancer Today at the 2023 American Urological Association (AUA) annual meeting, Janssen presented the first results from a comprehensive clinical program evaluating an investigational drug ...
Recognizing World IBD Day 2017
Recognizing World IBD Day 2017 Today, May 19 th, and every day, our focus at Janssen Immunology remains on advancing the science and understanding of Inflammatory Bowel Disease (IBD) with patients at the forefront. As a gastroenterologist who practiced ...
ASCO 2020 Virtual Newsroom
With the American Society of Clinical Oncology (ASCO) moving to a virtual platform for its 2020 Annual Meeting, Janssen Oncology remains determined in our efforts to champion science for patients. Thank you for visiting to check out our news from ASCO2020 ...